Gland Pharma Limited (BOM:543245)
India · Delayed Price · Currency is INR 2,922.70
-25.55 (-0.87%)
At close: Sep 11, 2026
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 482.08 billion as of September 11, 2026. Its market cap has increased by 53.80% in one year.
Market Cap
482.08B
Enterprise Value
451.33B
Revenue
67.25B
Ranking
n/a
PE Ratio
42.71
Stock Price
2,922.70
ChartMarket Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 482.08B, an increase of 62.26%. That is a compound annual growth rate of 8.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 482.08B | 69.92% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.88T |
| Dr. Reddy's Laboratories | 952.27B |
| Abbott India | 535.98B |
| GlaxoSmithKline Pharmaceuticals | 488.93B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 218.85B |
| Caplin Point Laboratories | 207.26B |
| AstraZeneca Pharma India | 172.48B |